News & AnalysisMedical device firm Nuclein picks up $14m Series BNuclein, a medical device firm, has secured $14 million in Series B funding.ByIris Dorbian26 March 2021•1 min readJavaScript is required to read this article. Please enable it in your browser and reload the page.DealsHealthcareBriefs